| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-10-09 |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-10-09 |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:03Z |
Prevention of mother-to-child transmission: the key of hepatitis B virus elimination
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Review article: the prevention of hepatitis B-related hepatocellular carcinoma
|
C.-L. Lin;J.-H. Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
|
Chao-Wei Hsu;Wei-Wen Su;Chuan-Mo Lee;Cheng-Yuan Peng;Wan-Long Chuang;Jia-Horng Kao;Heng-Cheng Chu;Yi-Hsiang Huang;Rong-Nan Chien;Yun-Fan Liaw; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
|
Chao-Wei Hsu;Wei-Wen Su;Chuan-Mo Lee;Cheng-Yuan Peng;Wan-Long Chuang;Jia-Horng Kao;Heng-Cheng Chu;Yi-Hsiang Huang;Rong-Nan Chien;Yun-Fan Liaw; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma
|
Ming-Hung Hu;Tzu-Ting Huang;Tzu-I Chao;Li-Ju Chen;Yen-Lin Chen;Ming-Hsien Tsai;Chun-Yu Liu;Jia-Horng Kao;Kuen-Feng Chen; JIA-HORNG KAO |
